Christie Ciarlo
About Christie Ciarlo
Christie Ciarlo is a Senior Scientist currently at Sana Biotechnology, Inc., with a diverse background in biomedical research spanning over a decade. She has held various roles at prestigious institutions including Harvard University, Brown University, and Novartis.
Current Role at Sana Biotechnology
Christie Ciarlo currently serves as a Senior Scientist at Sana Biotechnology, Inc. She has held this position since 2022. In her role, she focuses on advancing scientific research and development in the field of biotechnology. Her work contributes to the company's mission of developing transformative therapies for patients.
Previous Experience at Sana Biotechnology
Prior to her current role, Christie Ciarlo worked at Sana Biotechnology, Inc. as a Scientist from 2021 to 2022. During this time, she engaged in various research projects aimed at enhancing the understanding of biotechnological applications and their potential impacts on healthcare.
Education and Expertise
Christie Ciarlo earned her Bachelor of Science degree in Biophysics from Brown University, where she studied from 2005 to 2009. She furthered her education at Harvard University, obtaining a Doctor of Philosophy (PhD) from 2011 to 2017. Her academic background provides a strong foundation for her research in the biomedical sciences.
Research Experience at Altius Institute
From 2018 to 2021, Christie Ciarlo worked as a Research Fellow at the Altius Institute for Biomedical Sciences in the Greater Seattle Area. In this role, she conducted research that contributed to the understanding of various biomedical challenges, further enhancing her expertise in the field.
Early Career at Notable Institutions
Christie Ciarlo began her career as an Undergraduate Researcher at Brown University from 2008 to 2009. She then worked as a Scientific Intern at Novartis for two months in 2009 and as a Research Associate at the Broad Institute from 2009 to 2011. These early experiences laid the groundwork for her subsequent roles in research and development.